REGULATORY MECHANISMS IN CELL-MEDIATED IMMUNE RESPONSES. II. COMPARISON OF CULTURE-INDUCED AND ALLOANTIGEN-INDUCED SUPPRESSOR CELLS IN MLR AND CML.NADLER LM; HODES RJ.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 118; NO 5; PP. 1886-1895; BIBL. 7 REF.Article

ANTIGENS OF HUMAN MONOCYTES IDENTIFIED BY MONOCLONAL ANTIBODIESTODD RF III; NADLER LM; SCHLOSSMAN SF et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 4; PP. 1435-1442; BIBL. 49 REF.Article

REGULATORY MECHANISMS IN CELL-MEDIATED IMMUNE RESPONSES. III. ANTIGEN-SPECIFIC AND NONSPECIFIC SUPPRESSOR ACTIVITIES GENERATED DURING MLC.HODES RJ; NADLER LM; HATHCOCK KS et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 961-967; BIBL. 14 REF.Article

THE T LYMPHOBLASTIC MALIGNANCIESNADLER LM; REINHERZ EL; SCHLOSSMAN SF et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 1; PP. 11-15; BIBL. 62 REF.Article

STAGES OF B CELL DIFFERENTIATION IN HUMAN LYMPHOID TISSUEBHAN AK; NADLER LM; STASHENKO P et al.1981; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1981; VOL. 154; NO 3; PP. 737-749; BIBL. 31 REF.Article

HETEROGENEITY OF T-CELL LYMPHOBLASTIC MALIGNANCIESNADLER LM; REINHERZ EL; WEINSTEIN HJ et al.1980; BLOOD; ISSN 0006-4971; USA; DA. 1980; VOL. 55; NO 5; PP. 806-810; BIBL. 38 REF.Article

EXPRESSION OF CELL SURFACE MARKERS AFTER HUMAN B LYMPHOCYTE ACTIVATIONSTASHENKO P; NADLER LM; HARDY R et al.1981; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; ISSN 0273-1134; USA; DA. 1981; VOL. 78; NO 6; PP. 3848-3852; BIBL. 39 REF.Article

EXPRESSION OF MYELOID DIFFERENTIATION ANTIGENS ON NORMAL AND MALIGNANT MYELOID CELLSGRIFFIN JD; RITZ J; NADLER LM et al.1981; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1981; VOL. 68; NO 4; PP. 932-941; BIBL. 49 REF.Article

CHARACTERIZATION OF A HUMAN B LYMPHOCYTE-SPECIFIC ANTIGENSTASHENKO P; NADLER LM; HARDY R et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 4; PP. 1678-1685; BIBL. 44 REF.Article

A MONOCLONAL ANTIBODY DEFINING A LYMPHOMA-ASSOCIATED ANTIGEN IN MANNADLER LM; STASHENKO P; HARDY R et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 2; PP. 570-577; BIBL. 43 REF.Article

SUBSET DERIVATION OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN MANREINHERZ EI; NADLER LM; SALLAN SE et al.1979; J. CLIN. INVEST.; USA; DA. 1979; VOL. 64; NO 2; PP. 392-397; BIBL. 39 REF.Article

T-CELL-SUBSET CHARACTERIZATION OF HUMAN T-CLLREINHERZ EL; NADLER LM; ROSENTHAL DS et al.1979; BLOOD; USA; DA. 1979; VOL. 53; NO 6; PP. 1066-1075; BIBL. 37 REF.Article

MONOCLONAL ANTIBODY IDENTIFIES A NEW IA-LIKE (P29,34) POLYMORPHIC SYSTEM LINKED TO THE HLA-DIDR REGIONNADLER LM; STASHENKO P; HARDY R et al.1981; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1981; VOL. 290; NO 5807; PP. 591-593; BIBL. 23 REF.Article

PURIFICATION AND CHARACTERIZATION OF FETAL HEMATOPOIETIC CELLS THAT EXPRESS THE COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA) = PURIFICATION ET CARACTERISATION DES CELLULES HEMATOPOIETIQUES FOETALES QUI EXPRIMENT L'ANTIGENE COMMUN DE LA LEUCEMIE LYMPHOBLASTIQUE AIGUE (CALLA)HOKLAND P; ROSENTHAL P; GRIFFIN JD et al.1983; JOURNAL OF EXPERIMENTAL MEDICINE; ISSN 0022-1007; USA; DA. 1983; VOL. 157; NO 1; PP. 114-129; ABS. ENG; BIBL. 34 REF.; GRAPH, FIGArticle

CHARACTERIZATION OF A HUMAN B CELL-SPECIFIC ANTIGEN (B2) DISTINCT FROM B1NADLER LM; STASHENKO P; HARDY R et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 5; PP. 1941-1947; BIBL. 56 REF.Article

A UNIQUE CELL SURFACE ANTIGEN IDENTIFYING LYMPHOID MALIGNANCIES OF B CELL ORIGINNADLER LM; RITZ J; HARDY R et al.1981; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1981; VOL. 67; NO 1; PP. 134-140; BIBL. 49 REF.Article

SEROTHERAPY OF A PATIENT WITH A MONOCLONAL ANTIBODY DIRECTED AGAINST A HUMAN LYMPHOMA-ASSOCIATED ANTIGENNADLER LM; STASHENKO P; HARDY R et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 9; PP. 3147-3154; BIBL. 43 REF.Article

EXPRESSION OF COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA) BY LYMPHOMAS OF B-CELL AND T-CELL LINEAGERITZ J; NADLER LM; BHAN AK et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 58; NO 3; PP. 648-652; BIBL. 26 REF.Article

MONOCLONAL ANTIBODIES DEFINING SEROLOGICALLY DISTINCT HLA-D/DR RELATED IA-LIKE ANTIGENS IN MANNADLER LM; STASHENKO P; HARDY R et al.1981; HUM. IMMUNOL.; USA; DA. 1981; VOL. 2; NO 1; PP. 77-90; BIBL. 38 REF.Article

REACTIVITY OF A MONOCLONAL ANTIBODY WITH HUMAN OVARIAN CARCINOMABAST RC JR; FEENEY M; LAZARUS H et al.1981; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1981; VOL. 68; NO 5; PP. 1331-1337; BIBL. 43 REF.Article

T-CELL LYMPHOBLASTIC LYMPHOMA WITH SUBSEQUENT ACUTE NONLYMPHOCYTIC LEUKEMIAPOSNER MR; SAID J; PINKUS GS et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 1; PP. 118-124; BIBL. 35 REF.Article

COMPARISON IN T- AND B-CELL MARKERS IN PATIENTS WITH SJOEGREN'S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUSMORIMOTO C; REINHERZ EL; NADLER LM et al.1982; CLIN. IMMUNOL. IMMUNOPATHOL.; ISSN 0090-1229; USA; DA. 1982; VOL. 22; NO 2; PP. 270-278; BIBL. 36 REF.Article

DIAGNOSIS AND TREATMENT OF HUMAN LEUKEMIAS AND LYMPHOMAS UTILIZING MONOCLONAL ANTIBODIESNADLER LM; RITZ J; GRIFFIN JD et al.1981; PROG. HEMATOL.; ISSN 0079-6301; USA; DA. 1981; VOL. 12; PP. 187-225; BIBL. 175 REF.Article

EXPRESSION OF A 26000-DALTON GLYCOPROTEIN ON ACTIVATED HUMAN T CELLSHERCEND T; NADLER LM; PESANDO JM et al.1981; CELL. IMMUNOL.; ISSN 0008-8749; USA; DA. 1981; VOL. 64; NO 1; PP. 192-199; BIBL. 19 REF.Article

EXPRESSION OF NORMAL MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGENS ON HL60 PROMYELOCYTES UNDUCED BY LEUKOCYTE-CONDITIONED MEDIUM OR PHORBOL DIESTERTODD RF III; GRIFFIN JD; RITZ J et al.1981; LEUK. RES.; ISSN 0145-2126; USA; DA. 1981; VOL. 5; NO 6; PP. 491-495; BIBL. 8 REF.Article